Skip to content

Clinical trials

Phase 1/2 Recurrence trials in Norway

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Phase: Phase 1/2 Country / region: Norway Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20131
20181
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Princess Maxima Center for Pediatric Oncology3
Clavis Pharma1
Haukeland University Hospital1
Nykode Therapeutics ASA1
University of Bergen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence7
Leukemia4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma3
Glioblastoma1
Hematologic Neoplasms1
Leukemia, Myeloid, Acute1
Neoplasm Metastasis1
Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.